Tygh Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$8.96M Buy
80,031
+328
+0.4% +$36.7K 1.15% 41
2021
Q3
$10M Buy
79,703
+1,235
+2% +$155K 1.36% 31
2021
Q2
$10.6M Sell
78,468
-982
-1% -$133K 1.45% 25
2021
Q1
$10.8M Buy
79,450
+2,481
+3% +$337K 1.52% 27
2020
Q4
$10.8M Sell
76,969
-2,910
-4% -$410K 1.69% 15
2020
Q3
$8.9M Buy
79,879
+1,626
+2% +$181K 1.69% 19
2020
Q2
$8.76M Sell
78,253
-19,123
-20% -$2.14M 1.83% 16
2020
Q1
$7.54M Buy
97,376
+1,054
+1% +$81.6K 1.69% 25
2019
Q4
$9.16M Buy
+96,322
New +$9.16M 1.51% 28
2019
Q2
Sell
-102,421
Closed -$9.27M 87
2019
Q1
$9.27M Buy
102,421
+39,847
+64% +$3.61M 1.63% 22
2018
Q4
$4.49M Buy
62,574
+19,479
+45% +$1.4M 0.94% 48
2018
Q3
$4.13M Sell
43,095
-1,871
-4% -$179K 0.68% 66
2018
Q2
$4.28M Sell
44,966
-45,359
-50% -$4.32M 0.72% 68
2018
Q1
$7.92M Buy
90,325
+27,351
+43% +$2.4M 1.51% 23
2017
Q4
$5.35M Sell
62,974
-1,710
-3% -$145K 1.01% 43
2017
Q3
$5.6M Buy
64,684
+4,722
+8% +$409K 1.12% 41
2017
Q2
$4.63M Sell
59,962
-1,545
-3% -$119K 1.05% 50
2017
Q1
$4.27M Buy
61,507
+2,175
+4% +$151K 1% 53
2016
Q4
$3.51M Buy
+59,332
New +$3.51M 0.88% 56
2016
Q1
Sell
-27,853
Closed -$1.96M 98
2015
Q4
$1.96M Buy
27,853
+620
+2% +$43.5K 0.55% 70
2015
Q3
$1.7M Sell
27,233
-55,693
-67% -$3.47M 0.4% 80
2015
Q2
$6.97M Sell
82,926
-57
-0.1% -$4.79K 1.25% 32
2015
Q1
$6.24M Sell
82,983
-2,091
-2% -$157K 1.15% 33
2014
Q4
$5.29M Buy
+85,074
New +$5.29M 1.02% 41